John R. Cameron Symposium

Quantitative imaging is being increasingly used to diagnose disease, predict patients' outcomes, monitor treatment response, and identify eligible subjects for clinical trials. In this presentation, I first describe methods for the estimation and comparison of biomarkers' technical performance, then examine how these performance characteristics are used to design and analyze clinical trials and identify eligible trial subjects.